Company profile
Actimed Therapeutics company profile
Actimed Therapeutics is a clinical stage biopharmaceutical company focused on bringing innovation to the treatment of muscle wasting disorders to transform the care of an underserved and vulnerable patient population. The company produces anabolic/catabolic transforming agents to treat cachexia, an often deadly syndrome linked with a wide range of chronic illnesses, allowing healthcare providers to manage cancer-related cachexia. Actimed was founded in 2017 by Stefan Anker and Andrew Coats in Ascot, Windsor and Maidenhead.
Business identity
- Contact email
- [email protected]
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 1-10 employees
- Revenue range
- $0-$1M
- Founded
- 2017-01-01, Year
Headquarters
- Headquarters
- Bow Street, Wales, United Kingdom
- Postal code
- SL5 7HL
- Country code
- GB
- Continent
- Europe